MOUNTAIN VIEW, Calif., March 26, 2013 -- /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today reported financial results for the fiscal quarter and full year ended December 31, 2012. The net loss for the quarters ended December 31, 2012 and 2011, as reported in accordance with accounting principles generally accepted in the United States (GAAP), were $10.3 million and $9.7 million, respectively.
